IMNM Stock Summary and Trading Ideas (Immunome | NASDAQ:IMNM)

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Immunome trades on the NASDAQ stock market under the symbol IMNM.

As of November 11, 2026, IMNM stock price climbed to $19.07 with 823,171 million shares trading.

IMNM has a beta of 1.44, meaning it tends to be more sensitive to market movements. IMNM has a correlation of 0.12 to the broad based SPY ETF.

IMNM has a market cap of $2.25 billion. This is considered a Mid Cap stock.

Last quarter Immunome reported $0 in Revenue and -$.76 earnings per share. This fell short of revenue expectation by $-506,664 and missed earnings estimates by -$.15.

In the last 3 years, IMNM traded as high as $30.96 and as low as $5.15.

The top ETF exchange traded funds that IMNM belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWO.

IMNM has outperformed the market in the last year with a price return of +16.0% while the SPY ETF gained +12.6%. However, in the short term, IMNM had mixed performance relative to the market. It has underperformed in the last 3 months, returning -25.8% vs -1.5% return in SPY. But in the last 2 weeks, IMNM shares have fared better than the market returning +1.6% compared to SPY -1.3%.

IMNM support price is $17.85 and resistance is $19.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMNM shares will trade within this expected range on the day.